Wang Tianyu, Qiu Tao, Wang Ming, Yuan Yan, Chen Zhongbao, Ma Xiaoxiong, Zhang Long, Zou Jilin, Jin Zeya, Xu Yu, Zhang Yalong, Zhou Jiangqiao
Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan University, Wuhan 430060, China.
Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan University, Wuhan 430060, China.
Transpl Immunol. 2021 Aug;67:101395. doi: 10.1016/j.trim.2021.101395. Epub 2021 Apr 22.
Since its emergence in December 2019 many end-stage renal disease (ESRD) patients have been infected with coronavirus disease 2019 (COVID-19). Herein, we describe the case of an ESRD patient who received a kidney transplant after recovering from COVID-19. We described the clinical course of COVID-19 and kidney transplant management, including the patient's symptoms, laboratory results, computed tomography, and antibody profiles. He recovered well, without complications. Chest computed tomography, PCR, and IgG results indicated no recurrence of COVID-19 during the subsequent two weeks. Therefore, kidney transplantation is feasible in an ESRD patient who has recovered from COVID-19, under a normal immunosuppressive regimen.
自2019年12月出现以来，许多终末期肾病（ESRD）患者感染了2019冠状病毒病（COVID-19）。在此，我们描述了一例ESRD患者在从COVID-19康复后接受肾移植的病例。我们描述了COVID-19的临床过程和肾移植管理，包括患者的症状、实验室检查结果、计算机断层扫描和抗体谱。他恢复良好，没有并发症。胸部计算机断层扫描、聚合酶链反应（PCR）和IgG结果表明，在随后的两周内没有COVID-19复发。因此，在正常免疫抑制方案下，对于从COVID-19康复的ESRD患者，肾移植是可行的。
